Evidence map›Paper›PMID 36158935›Full record

ArticleThe Pan African medical journal2022

Analysis of the 2017-2018 Rift valley fever outbreak in Yirol East County, South Sudan: a one health perspective.

Otim Patrick Cossy Ramadan, Kibebu Kinfu Berta, Joseph Francis Wamala, Sylvester Maleghemi, John Rumunu, Caroline Ryan, Alice Igale Ladu, Julu Louis Kenyi Joseph, Abraham Aduet Abenego, Fabian Ndenzako and 1 more

Abstract read
In one paragraph

Article in The Pan African medical journal, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Otim Patrick Cossy RamadanWorld Health Organization, East and South Africa, Sub Regional Office, Nairobi, Kenya.
Kibebu Kinfu BertaWorld Health Organization (WHO), WHO Country Office, Juba, South Sudan.
Joseph Francis WamalaWorld Health Organization (WHO), WHO Country Office, Juba, South Sudan.
Sylvester MaleghemiWorld Health Organization (WHO), WHO Country Office, Juba, South Sudan.
John RumunuMinistry of Health, Juba, Republic of South Sudan.
Caroline RyanWorld Health Organization, East and South Africa, Sub Regional Office, Nairobi, Kenya.
Alice Igale LaduWorld Health Organization (WHO), WHO Country Office, Juba, South Sudan.
Julu Louis Kenyi JosephWorld Health Organization (WHO), WHO Country Office, Juba, South Sudan.
Abraham Aduet AbenegoWorld Health Organization (WHO), WHO Country Office, Juba, South Sudan.
Fabian NdenzakoWorld Health Organization (WHO), WHO Country Office, Juba, South Sudan.
Olushayo Oluseun OluWorld Health Organization, East and South Africa, Sub Regional Office, Nairobi, Kenya.

Funding

World Health Organization 001
6 · The paper itself

Abstract

Introduction: the emergence and re-emergence of zoonotic diseases have threatened both human and animal health globally since their identification in the 20th century. Rift Valley fever (RVF) virus is a recurrent zoonotic disease in South Sudan, with the earliest RVF cases confirmed in 2007 in Kapoeta North County, Eastern Equatoria state. Methods: we analyzed national RVF outbreak data to describe the epidemiological pattern of the RVF outbreak in Yirol East county in Lakes State. The line list of cases (confirmed, probable, suspected, and non-cases) was used to describe the pattern and risk factors associated with the outbreak. The animal and human blood samples were tested using Enzyme-Linked Immunosorbent Assay (ELISA) (Immunoglobulin IgG and IgM) and Reverse Transcriptase-Polymerase Chain Reaction (RT-PCR). Qualitative data were collected from weekly RVF situation reports, and national guidelines and policies. Results: between December 2017 and December 2018, 58 suspected human RVF cases were reported. The cases were reclassified based on laboratory and investigations results, such that as of 16th December 2018, there were a total of six (10.3%) laboratory-confirmed, three (5.2%) probable, one (1.7%) suspected, and 48 (82.8%) non-cases were reported. A total of four deaths were reported during the outbreak (case fatality rate (CFR) 6.8% (4/58). A total of 28 samples were collected from animals; of these, six tested positives for RVF (positivity rate of 32.1% (9/28). The outbreak was announced in March 2018, after four months of the first reported suspected RVF case. Several factors were attributed to the delayed notification and outbreak announcement such as lack of multi-sectorial coordination at the state and county level, multi-sectoral coordination at national level mostly attended by public health experts from human health, inadequate animal health surveillance, poor coordination between livestock disease surveillance and public health surveillance, limited in-country laboratory diagnostic capacity, the laboratory results for the animal health took longer than expected, and lack of a national One Health approach strategy. Conclusion: the outbreak demonstrated gaps to investigate and respond to zoonotic disease outbreaks in South Sudan.

Indexed as

One HealthRift Valley FeverRift Valley fever virusAnimalsDisease OutbreaksHumansImmunoglobulin GImmunoglobulin MRNA-Directed DNA PolymeraseSouth SudanZoonosesImmunoglobulin GImmunoglobulin MRNA-Directed DNA Polymeraseone healthRift Valley fever (RVF)South Sudansurveillancezoonotic disease

Identifiers

PMID36158935
PMCPMC9474954

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.